05025=BIA AlzBio3 leaflet def2
04-03-2005
13:31
Pagina 1
INNO-BIA AlzBio3
Choose high performance
and ease of use
* xMAP® is a registered trademark of the Luminex® Corporation (Austin, TX).
Simultaneous measurement of
Aß1-42, total tau, and P-tau181P in CSF
using the xMAP® technology*
For Research Use Only. Not For Use in Diagnostic Procedures. For use outside the US.
© Innogenetics 2005
A multiparameter bead-based immunoassay for the simultaneous measurement of ß-amyloid1-42 (Aß1-42), total tau,
and tau phosphorylated at threonine 181 (P-tau181P) in human cerebrospinal fluid (CSF) using the xMAP® technology. 1
05025=BIA AlzBio3 leaflet def2
04-03-2005
13:31
Pagina 2
INNO-BIA AlzBio3
Multiparameter assay
■ Simultaneous measurement of Aß1-42, tau, and P-tau181P
■ Only one assay
High performance 1
Ease of use
■ Low intra- and interassay variability,
even at low concentrations
■ High reproducibility
■ Broad dynamic range
■ Only one test procedure
■ Six ready-to-use (multiparametric) standards
■ Inclusion of two run-validation
control samples
■ Limited number of handling steps
■ Reduced hands-on-time
■ Sample: undiluted (75 µL) per well
96 wells/kit
Your Agent:
Commercial office: INNOGENETICS NV
Technologiepark 6 - 9052 GENT - BELGIUM
Tel. +32-9-329-1329 - Fax +32-9-329-1775
www.innogenetics.com
art. no.
80584
05025
Presentation
INNO-BIA AlzBio3
15501 © Innogenetics 2005
Reference:
1. Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, et al. Simultaneous Measurement of Aß(1-42), Total Tau, and
Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology. Clin Chem 2005;51:336-345.
For Research Use Only. Not For Use in Diagnostic Procedures.
xMap® technology